Atomoxetine Related Compounds & Impurities

Atomoxetine is a selective norepinephrine reuptake inhibitor used as a non-stimulant pharmacotherapy for ADHD in children and adults.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Atomoxetine reference standards, pharmacopeial and non-pharmacopeial Atomoxetine impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Atomoxetine-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Atomoxetine Hydrochloride
Atomoxetine
N-Desmethyl Atomoxetine Hydrochloride
Atomoxetine EP Impurity B Hydrochloride
S-(+)-Atomoxetine
R-(-)-Atomoxetine
4-Hydroxy Atomoxetine
Atomoxetine EP Impurity A Hydrochloride
Atomoxetine N-amide
3,3`-oxybis(1-phenylpropan-1-one)
3-Hydroxypropanoyl Chloride
Atomoxetine EP Impurity H
Atomoxetine USP Related Compound C
3-Chloro-1-phenyl-1-propanol
Atomoxetine Related Compound B Hydrochloride
Desmethyl Atomoxetine Impurity
3-(Methylamino)-1-phenylpropan-1-one
Atomoxetine Impurity 1
Atomoxetine EP Impurity F
Atomoxetine EP Impurity G
3,3'-((2-methyl-1,3-phenylene)bis(oxy))bis(N-methyl-3-phenylpropan-1-amine) dihydrochloride
N,N-dimethyl-3-[2-methyl phenoxy]-3-phenyl propylamine
2-methylthioanisole
N-Nitroso-Atomoxetine
Atomoxetine Impurity G Dihydrochloride
N-Nitroso-Atomoxetine Hydrochloride
N-(3-chloro-3-phenylpropyl)-N-methylnitrous amide hydrochloride
Atomoxetine Impurity 2
Atomoxetine EP Impurity D Hydrochloride
Atomoxetine N-Desmethyl Impurity
Atomoxetine Impurity 3
N-Formyl Atomoxetine
2-Hydroxymethyl Atomoxetine
4-Hydroxy Atomoxetine Hydrochloride
Atomoxetine EP Impurity C
Atomoxetine Impurity 6
Atomoxetine EP Impurity F (Racemic mixture)
Atomoxetine Nitroso Impurity A
Atomoxetine Nitroso Impurity C
Atomoxetine Nitroso Impurity D
N-Nitroso Atomoxetine EP Impurity F
N-Nitroso Atomoxetine EP Impurity G
Desmethyl Atomoxetine Hydrochloride
Atomoxetine Impurity 4
Atomoxetine Nitroso Impurity 1
Atomoxetine Nitroso Impurity 2

Metabolites

4`-Hydroxy Atomoxetine beta-D-Glucuronide
N-Desmethyl-4-Hydroxy Atomoxetine

Isotope Labelled Compounds

Atomoxetine D3 Hydrochloride
Atomoxetine-D5
Atomoxetine-D7
rac N-Nitroso-Atomoxetine D3
Atomoxetine D7 Hydrochloride